🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with apob reduction on tirzepatide? Page 7

Has anyone dealt with apob reduction on tirzepatide?

tampaLisa73 Sat, Apr 26, 2025 at 11:05 AM 41 replies 2,416 viewsPage 7 of 9
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Aug 21, 2025 at 7:45 PM#31
MASHdoc_SA said:
The version of this that has an answer is narrower than the version being asked.

Adding the part of the answer the thread has not reached. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

18 16maya_sedona, stefan_berlin, Dr.EM_Chicago and 15 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Aug 31, 2025 at 3:41 AM#32

The figures, for anyone assembling their own picture. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

Worth separating that from the lipid panel, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Aug 31, 2025 at 8:41 AM
19 17Dr.PathRoch, mona_PHX, andrew_nyc and 16 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Sep 9, 2025 at 11:43 AM#33

One thing that is still open after MASHdoc_SA’s answer:

Was that from a primary source or from a summary of one?

20 18PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Sep 18, 2025 at 7:50 PM#34
jason_paloalto said:
One practical note: write down what you did and when, before you need it.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

21 19FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 18 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Sep 28, 2025 at 4:02 AM#35
jason_paloalto said:
One practical note: write down what you did and when, before you need it.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

22 20wanda_boise, NurseAsh_DET, BenResearch_OR and 19 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register